Lifegene- Biomarks Inc.
San Juan, San Juan
- UEI
- GGR9ABCTBGG5
- CAGE
- 7RTK5
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1612 Av. Juan Ponce de León, San Juan, 00912, Puerto Rico
- Website
- lifegenedna.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Lifegene-Biomarks Inc. is a minority-owned, for-profit corporation specializing in the development and commercialization of innovative epigenetic screening technologies for cancer detection and prevention. Registered to receive federal awards since November 2016, the company focuses on addressing health disparities, particularly among minority and low-income populations. Lifegene-Biomarks Inc. has received multiple federal grant awards from the National Institutes of Health to support its research and development efforts in precision medicine and cancer screening.
The company's federal grant awards have primarily supported the development of DNA methylation-based tests for cancer screening and risk stratification. Notable projects include the CervicalMethDx test, designed to stratify high-risk HPV-positive Latina women for cervical cancer risk using self-collected vaginal samples, funded by the National Institute on Minority Health and Health Disparities. Another significant project is the OralMethDx test, aimed at stratifying patients at high risk of oral cavity squamous cell carcinoma, with a focus on African American and low-income populations, funded by the National Cancer Institute. These projects involve partnerships with healthcare providers, research institutions, and clinical laboratories to promote early detection and reduce cancer disparities in underserved communities. Lifegene-Biomarks Inc.'s work aligns with federal initiatives to improve cancer screening and prevention, particularly in low-resource settings and among minority populations in the United States and Latin America.
Quick answers
Is Lifegene- Biomarks Inc. registered in SAM.gov?
Yes. Lifegene- Biomarks Inc.'s SAM.gov registration is active through August 1, 2027.
What is Lifegene- Biomarks Inc.'s most recent federal award?
Lifegene- Biomarks Inc.'s most recent federal grant award is Precision screening in self-collected samples to reduce cervical cancer disparities among latinas (R42MD018231), from National Institute for Minority Health and Health Disparities (NIH), on June 1, 2024.
On GovTribe
See Lifegene- Biomarks Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors